Thomas Shrader

Stock Analyst at BTIG

(0)
# 4759
Out of 5,441 analysts
72
Total ratings
Success rate
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
HROW Harrow
Maintains: Strong Buy
62 63
33.76 86.61% 1 Aug 14, 2025
VRNA Verona Pharma
Downgrades: Neutral
n/a
n/a n/a 4 Jul 10, 2025
INMB INmune Bio
Downgrades: Neutral
n/a
n/a n/a 3 Jul 1, 2025
ALDX Aldeyra Therapeutics
Maintains: Buy
11 9
5.24 71.76% 1 Apr 7, 2025
OVID Ovid Therapeutics
Maintains: Buy
5 4
0.56 614.29% 3 Mar 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
160 160
29.7 438.72% 4 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
41
11.39 259.96% 1 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 5
2.24 123.21% 2 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
2.05 290.24% 1 May 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
0.6 1233.33% 1 Oct 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
180 60
4.36 1276.15% 1 Jul 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jun 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
24 24
13.43 78.7% 2 Jun 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 7
2.35 197.87% 2 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
6.09 146.31% 1 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
68 13
n/a n/a 3 Mar 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 10
1.46 584.93% 2 Nov 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
400 150
n/a n/a 2 Oct 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 22
1.41 1460.28% 2 Oct 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
51
1.69 2917.75% 1 Apr 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
10.2 56.86% 1 Mar 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
220
n/a n/a 1 Mar 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
2.23 617.49% 1 Mar 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Feb 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Oct 16, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Sep 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
51 58
8.76 562.1% 1 Sep 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
29
10.5 176.19% 1 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 3
1.35 122.22% 3 Apr 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
1440 840
0.66 127172.73% 3 Aug 2, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
397 346
128.03 170.25% 3 Feb 21, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 3 Feb 22, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 1 Oct 27, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Jun 30, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
360 0
n/a n/a 1 May 8, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Mar 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 10
n/a n/a 1 Mar 4, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Mar 4, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Mar 4, 2016